Phase 4 Sickle Cell Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Sickle Cell Disease
Novartis Pharmaceuticals130 enrolled30 locationsNCT04657822
Recruiting
Phase 4
Stroke Prevention in Nigeria 2 Trial
StrokeSickle Cell Disease
Vanderbilt University Medical Center220 enrolled2 locationsNCT06526117
Recruiting
Phase 4
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Sickle Cell Disease (SCD)Vaso-Occlusive Pain Episode in Sickle Cell Disease
University of Pennsylvania65 enrolled2 locationsNCT06665997
Recruiting
Phase 4
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Sickle Cell DiseasePregnancy Related
Emory University50 enrolled1 locationNCT06979492
Recruiting
Phase 4
Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
Sickle Cell Anemia (HbSS)Sickle-β0-thalassemia (HbSβ0)
Children's Hospital Medical Center, Cincinnati50 enrolled1 locationNCT07177300
Recruiting
Phase 4
Effects of the Contraceptive Implant in Women With Sickle Cell Disease
Sickle Cell Disease
University of Pennsylvania22 enrolled1 locationNCT05730205